

Find a hematologist or oncologist who prescribes Agrylin (Anagrelide) near you. Learn which doctors prescribe it, how to get a referral, and what to expect at your first visit.
If you've been told you need Agrylin (Anagrelide) to manage your platelet count, your next step is finding a doctor who can prescribe it. Agrylin isn't the kind of medication a general practitioner typically handles — it's a specialty drug used for myeloproliferative neoplasms, so you'll need to see the right specialist.
This guide walks you through exactly how to find a prescribing doctor near you, what to expect at your appointment, and how to make the process as smooth as possible.
Agrylin is primarily prescribed by:
Because Agrylin is used to treat thrombocythemia secondary to myeloproliferative neoplasms — conditions where your bone marrow makes too many platelets — it requires a specialist who understands these disorders and can monitor your treatment closely.
Your primary care doctor likely won't prescribe Agrylin directly, but they're the best starting point for getting a referral.
The most practical first step is searching your insurance company's provider directory. This ensures you find in-network specialists, keeping your out-of-pocket costs lower.
Online doctor-finding platforms can help you locate specialists and book appointments:
Search for "hematologist" and filter by your insurance plan. Look for doctors who list myeloproliferative neoplasms or essential thrombocythemia as conditions they treat.
If you have an HMO plan or simply want a trusted recommendation, ask your primary care physician. They can:
Most insurance plans require a referral from your PCP before they'll cover a specialist visit. Even if yours doesn't, a referral can help you skip the intake paperwork and get seen faster.
If you're near a university hospital or academic medical center, these often have dedicated myeloproliferative neoplasm (MPN) clinics. Major centers like MD Anderson, Memorial Sloan Kettering, and Mayo Clinic have specialized teams, but many regional university hospitals offer excellent care as well.
These centers may also have clinical trial options if standard treatment isn't working well for you.
While your initial evaluation for Agrylin typically needs to be in person — it requires a physical exam, ECG, and blood work — some hematologists offer telehealth visits for follow-up appointments. This can be convenient once your treatment is established and your platelet counts are stable.
Note that Agrylin is not commonly prescribed through telehealth-only services, as it requires careful cardiovascular monitoring before starting treatment.
Your first visit with a hematologist will likely include:
Bring a list of all medications, supplements, and over-the-counter drugs you take. Agrylin has important drug interactions your doctor needs to know about.
Don't leave your appointment without asking:
Once your doctor writes a prescription for Agrylin, you'll need to fill it at a pharmacy. A few things to keep in mind:
Finding the right doctor for Agrylin doesn't have to be overwhelming. Start with your insurance directory or a referral from your primary care doctor, look for a hematologist or hematology-oncologist, and make sure they have experience with myeloproliferative neoplasms.
The right specialist will not only prescribe Agrylin but also monitor your treatment carefully — including regular blood counts and cardiac checks — to make sure it's working safely.
Need help finding Agrylin at a pharmacy near you? Medfinder can help you locate it in stock today.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.